Online education platform StraighterLine announced today its new strategic initiative with longtime partner Bellevue University that will offer students an accelerated, fully online applied associate ...
Millions of U.S. adults enroll in credit and non-credit college courses to earn professional certificates, learn new skills or to pursue academic degrees. Some older students are seeking career ...
Nashville, Tenn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Trevecca Nazarene University has launched a reimagined Master of Business Administration (MBA) degree with a 10-month accelerated option that’s one ...
Mississippi State, a longtime leader in One Health principles, now is offering two new graduate programs focusing on this public health approach that recognizes the interconnectedness of animal, human ...
Alabama tackles a critical nursing shortage, with nearly 40,000 departures outpacing new graduates. Educational institutions and medical providers unite to expand training programs, promising a ...
“Incorporating ctDNA into the decision-making process helps refine who can safely keep their bladder,” Ghatalia, associate professor, Department of Hematology/Oncology, at Fox Chase Cancer Center in ...
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathologyKNOXVILLE, Tenn. and PHILADELPHIA , Feb. 17, 2026 (GLOBE NEWSWIRE) -- NeuroScience Associates (NSA Labs) ...
Campuses have long been thought of as places of open debate and dialogue. But some students and faculty are now ...
As tuition climbs and skepticism grows, three‑year degree pathways offer an innovative solution for students and employers alike.
With GenAI deployment delivering measurable business results, financial services firms are doubling down on technology transformation and taking aim at the tokenization of market infrastructure.
The Narwhal reports Canada’s largest nickel mine aims to utilize carbon-capturing brucite in its waste to store over a ...
Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...